Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share
-
Shares outstanding
-
49,720,826
-
Total 13F shares
-
11,420,900
-
Share change
-
+4,092,465
-
Total reported value
-
$341,205,000
-
Price per share
-
$29.87
-
Number of holders
-
39
-
Value change
-
+$123,065,825
-
Number of buys
-
26
-
Number of sells
-
11
Institutional Holders of BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share (BCYC) as of Q1 2021
As of 31 Mar 2021 BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share (BCYC) had 39 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 11,420,900 shares of stock of the company.
Largest 10 holders included TYBOURNE CAPITAL MANAGEMENT (HK) LTD, SV Health Investors, LLC, JANUS HENDERSON GROUP PLC, Point72 Asset Management, L.P., Logos Global Management LP, Atlas Venture Advisors, Inc., FIL Ltd, SAMLYN CAPITAL, LLC, EVENTIDE ASSET MANAGEMENT, LLC, and Verition Fund Management LLC.
This table shows 39 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.